A batch of COVID-19 vaccines – 698,500 doses of COVISHIELD, the Indian analogue of AstraZeneca/Oxford vaccine – was delivered from India to Tajikistan yesterday night under the COVAX mechanism with the support from UNICEF.
India was the first country to deliver COVID-19 vaccines – 192,000 doses of COVISHILED – to Tajikistan in March 2021 under the COVAX mechanism.
COVISHIELD, manufactured by SIIPL was assessed under the WHO EUL procedure based on the review of data on quality, safety, efficacy, risk management plan (RMP) and programmatic suitability performed by WHO Vaccine Prequalification experts and evaluators from National Regulatory Authorities (NRAs) from different countries and regions.
Tajikistan began COVID-19 vaccination campaign on March 23, 2021.
According to statistical data from the Ministry of Health and Social Protection of the Population (MoHSPP), 6,137,700 doses of five types of vaccines, including COVISHIELD, China’s CoronaVac, Russia’s Sputnik V and the United States’ Moderna and Pfizer, have been delivered to Tajikistan to date.
As of November 30, 3,206,063 (51.8 percent) people in Tajikistan have received the first dose of the COVID-19 vaccine, with 2,590,545 of them (44.5 percent) having received both doses.
